Lovastatin for the Treatment of Adult Patients With Dengue: A Randomized, Double-Blind, Placebo-Controlled Trial - Wikidata - wikimedia - TriplyDB

Lovastatin for the Treatment of Adult Patients With Dengue: A Randomized, Double-Blind, Placebo-Controlled Trial

Lovastatin for the Treatment of Adult Patients With Dengue: A Randomized, Double-Blind, Placebo-Controlled Trial

http://www.wikidata.org/entity/Q36497872

about

Extended Evaluation of Virological, Immunological and Pharmacokinetic Endpoints of CELADEN: A Randomized, Placebo-Controlled Trial of Celgosivir in Dengue Fever Patients Recent advances in understanding dengue Genomic approaches for understanding dengue: insights from the virus, vector, and host Treating the host response to emerging virus diseases: lessons learned from sepsis, pneumonia, influenza and Ebola.Management and outcomes of severe dengue patients presenting with sepsis in a tropical country 18F-FDG as an inflammation biomarker for imaging dengue virus infection and treatment response Current Status of Dengue Therapeutics Research and Development.Therapeutic Potential of Spirooxindoles as Antiviral Agents Genetic variants of MICB and PLCE1 and associations with the laboratory features of dengue Zika antiviral chemotherapy: identification of drugs and promising starting points for drug discovery from an FDA-approved library.DENV up-regulates the HMG-CoA reductase activity through the impairment of AMPK phosphorylation: A potential antiviral target.Investigational drugs in early development for treating dengue infection.Endothelial nitric oxide pathways in the pathophysiology of dengue: a prospective observational study.Case Management of Dengue: Lessons Learned.Peptides as Therapeutic Agents for Dengue Virus.Dengue virus causes changes of MicroRNA-genes regulatory network revealing potential targets for antiviral drugs.Neutralization of antibody-enhanced dengue infection by VIS513, a pan serotype reactive monoclonal antibody targeting domain III of the dengue E protein.A preliminary study on efficacy of rupatadine for the treatment of acute dengue infection.Biochemistry and Molecular Biology of Flaviviruses.Antiviral Effects of Clinically-Relevant Interferon-α and Ribavirin Regimens against Dengue Virus in the Hollow Fiber Infection Model (HFIM)The Role of Host Cholesterol During Flavivirus Infection

P2860

Q26257542-C70AACEC-FF69-495E-A43C-606B50B4BBD0 Q26766156-1B6D2467-4006-4FD1-8E87-2D0E24D575DD Q28073351-A34421CE-6F3E-4075-9C0E-A5CDDC5B1305 Q28076034-1CCE5E2E-EE6B-49AD-A3FF-D697E26B6B9B Q29571044-6E9EA77C-F4F4-4012-9942-0596ECB29C10 Q30250993-99F263D4-FB0A-4A51-AC6B-68414BF86825 Q33552896-A2C7A6CB-BDF0-418E-8200-6B8595AADA55 Q33637160-003BD8CC-0984-4536-9FEA-DA3989DD960D Q33785152-6C7E0BB9-62AB-4B7C-9687-1B2542A7289B Q36210865-00C2253E-FB50-48BE-8009-F97CF2F8CFB4 Q36338285-44066BD4-34B8-422A-A7E5-17D7AFCBB0B1 Q38870485-0280FA40-894E-419E-B97C-7216EA56A488 Q39609743-20CDA4F8-1DE3-4D73-A205-C65CA97A4CC3 Q40061338-C02BF468-ACF4-458C-8ECD-E3416DF2D09A Q45323856-3395FE4B-01FD-4DC9-9F11-0867A01AD3F2 Q47165163-E23000BC-A582-4E7D-B768-AF9719FE1366 Q50099498-3268D6F7-B5F6-444F-9EDA-875D1BD55F03 Q51745540-934B60C6-AA33-4EA5-AE1F-50197F194AFE Q55277816-BEA3C1D8-7BF9-427D-A823-9A1BE4598C84 Q56479686-7FBEA3AA-754C-4E60-8F53-EBC52650FBD1 Q59132140-B97F5327-44BD-4E6F-898A-D3AE258975A5

P2860

Lovastatin for the Treatment of Adult Patients With Dengue: A Randomized, Double-Blind, Placebo-Controlled Trial

http://www.wikidata.org/entity/Q36497872

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Lovastatin for the Treatment o ...... lind, Placebo-Controlled Trial

@ast

Lovastatin for the Treatment o ...... lind, Placebo-Controlled Trial

@en

type

label

Lovastatin for the Treatment o ...... lind, Placebo-Controlled Trial

@ast

Lovastatin for the Treatment o ...... lind, Placebo-Controlled Trial

@en

prefLabel

Lovastatin for the Treatment o ...... lind, Placebo-Controlled Trial

@ast

Lovastatin for the Treatment o ...... lind, Placebo-Controlled Trial

@en

P1433

Q36497872-ADD4216B-B1E6-4A90-A91B-C16DBC4AD090

P1476

Q36497872-05419E0F-B6D1-4E34-BAF8-9A5B69706CE4

P2093

Q36497872-1D9CC388-480D-4CD9-82DC-9F916B65546A

Q36497872-318F4D0F-3300-426C-93DA-1ABD1B038C2A

Q36497872-7B9054C9-093C-4C1C-B3A8-76132FD2ADD0

Q36497872-810D02A9-9E03-47BB-ABBD-D253B52BBBFE

Q36497872-88285805-147B-41C5-B44D-91FCD347824E

Q36497872-90E394FE-FC7C-4AFA-8F47-FAEB5D9A234B

Q36497872-A1BF5E91-6B80-45AC-96C7-63B697946D06

Q36497872-B0EC2B94-9A40-4464-AFC2-A634E8058112

Q36497872-B575E690-073A-4490-89E5-98C9E8E4CBBE

Q36497872-CBEB348B-93DF-49B2-B29B-711D6FEAE476

P2860

Q36497872-216A2C7D-A5BA-46F7-B013-DBBE92332BF5

Q36497872-37A3D5BE-D8F7-4BCA-A8CC-0D506FCA20AE

Q36497872-4625ABF4-E051-45A3-9E20-EACC92059996

Q36497872-467F521E-1E88-42B9-85FF-CCDEBCE44498

Q36497872-469CCA47-56AB-40F0-BBCD-56D7CF414040

Q36497872-4A3B5DFA-6727-4CF4-BA89-AD545B9B6116

Q36497872-4B23089E-C465-4709-A64A-6B13E9E7F388

Q36497872-548861CC-55A0-4542-9133-9B795BD89CA0

Q36497872-54C442FC-8B0F-48A1-ACFB-C0BDBDFB8FA6

Q36497872-5788C031-3E4F-4443-924E-12A5E36CE05A

P304

Q36497872-2BF22928-8BEA-445A-AFE6-D800CF3E3A7B

P31

Q36497872-16E9D3CA-DCA5-44CF-8D7B-3224663B96BE

P356

Q36497872-683F6027-4668-463A-81FF-4B5F4663D040

P407

Q36497872-CB6DF1E2-F513-49EC-BF3F-F32CE1C49D53

P433

Q36497872-6523E517-0EB5-4D84-912C-643253163128

P478

Q36497872-CDD66E75-11F1-4C4F-9527-3608DF0B245D

P50

Q36497872-70D2EABF-25DE-4EAD-90A3-A6125D5AD69A

Q36497872-AE07F633-26C7-48E4-BD0A-C9E7B4B97D54

Q36497872-E2B09B7D-DD7D-4CDE-AAF2-1CA43B17E638

Q36497872-F292654B-0B66-4877-AD11-C85A932A3C8F

P577

Q36497872-9E215C1F-8480-4F7B-911D-423BFF4E6857

P698

Q36497872-C22A8979-CD90-4020-895E-1AC79A2772B3

P921

Q36497872-8153F99E-F56D-45E0-8BAF-B3DF859693D2

Q36497872-BA87694A-7D8F-4BFA-9F7C-C7A3378BC2B8

P932

Q36497872-70004628-2B94-4EBB-8772-01102FDAE02E

P356

P1433

Clinical Infectious Diseases

P1476

Lovastatin for the Treatment o ...... lind, Placebo-Controlled Trial

@en

P2093

Chau Van Vinh Nguyen

http://www.w3.org/2001/XMLSchema#string

Duong Thi Hue Kien

http://www.w3.org/2001/XMLSchema#string

James Whitehorn

http://www.w3.org/2001/XMLSchema#string

Lam Phung Khanh

http://www.w3.org/2001/XMLSchema#string

Luong Thi Hue Tai

http://www.w3.org/2001/XMLSchema#string

Nguyen Than Ha Quyen

http://www.w3.org/2001/XMLSchema#string

Nguyen Thanh Truong

http://www.w3.org/2001/XMLSchema#string

Nguyen Thi Cam Huong

http://www.w3.org/2001/XMLSchema#string

Nguyen Thi Thanh Tran

http://www.w3.org/2001/XMLSchema#string

Nguyen Thuy Hang

http://www.w3.org/2001/XMLSchema#string

P2860

Predicting outcome from dengue

The global distribution and burden of dengue

The effect of prior statin use on 30-day mortality for patients hospitalized with community-acquired pneumonia.

Non-cardiovascular effects associated with statins

A randomized controlled trial of chloroquine for the treatment of dengue in Vietnamese adults

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

Association of statin therapy and increased survival in patients with multiple organ dysfunction syndrome.

Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections.

Clinical features of dengue in a large Vietnamese cohort: intrinsically lower platelet counts and greater risk for bleeding in adults than children.

P304

468-476

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CID/CIV949

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

62

http://www.w3.org/2001/XMLSchema#string

P50

Cameron P. Simmons

P577

2015-11-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26565005

http://www.w3.org/2001/XMLSchema#string

P921

P932

4725386

http://www.w3.org/2001/XMLSchema#string